Five-Year Cardiorenal Outcomes and Longitudinal Chronic Kidney Disease Screening in People with Type 2 Diabetes Managed by Endocrinologists: A Nationwide Retrospective Cohort Study
Medical Sciences · 21.08.2026 · 14 (4) · 506
DOI: 10.3390/medsci14040506 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Medical Sciences, online erschienen am 21.08.2026. Verfasst von José Ignacio Martínez-Montoro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Nutrition, Hospital Universitario Virgen de la Victoria, IBIMA Plataforma BIONAND, Instituto de Investigación Biomédi…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, AstraZeneca (Spain), Fondo Europeo de Desarrollo Regional.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background/Objectives: Type 2 diabetes (T2D) is a major risk factor for cardiovascular disease and chronic kidney disease (CKD), yet the extent of longitudinal CKD screening in routine clinical practice remains unclear. This study aimed to assess long-term cardiorenal outcomes and CKD screening practices in patients with T2D managed across primary care and endocrinology settings, evaluating the feasibility of risk stratification in real-world practice.
Methods
We conducted a retrospective cohort study using anonymized data from the Telotrón database (2.2 million patients). Adults with T2D attended across primary and endocrinology care were followed from 1 January 2018 to 31 December 2022. Frequency of estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR) measurements, and cumulative proportion of kidney and cardiovascular events, hospitalizations, and mortality were assessed.
Results
Among 13,600 individuals, 31.1% experienced a kidney event and 18.6% a cardiovascular event over 5 years. All-cause hospitalization occurred in 24.9% and 16.1% died. First occurrence of an abnormal eGFR or UACR measurement occurred in 37.0% of participants without baseline CKD, and 45.4% with baseline CKD showed progression. Annual monitoring was limited, with 39.1% and 16.6% undergoing at least one yearly assessment, and 2.9 and 1.5 mean number of measurements per patient for eGFR and UACR, respectively.
Conclusions
Despite receiving endocrinology care, kidney disease progression and cardiovascular events remain a major concern in T2D, and yet suboptimal albuminuria and eGFR assessment limit early detection and risk stratification, thereby hindering risk-directed management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Nutrition, Hospital Universitario Virgen de la Victoria, IBIMA Plataforma BIONAND, Instituto de Investigación Biomédica de Málaga, Faculty of Medicine, University of Málaga, 29010 Málaga,…
- Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y la Nutrición (CIBERObn), Instituto de Salud Carlos III, 28029 Madrid, Spain.
- Medical Department, BioPharmaceuticals, AstraZeneca, 28046 Madrid, Spain.
- Telómera SLU, 28001 Madrid, Spain.
- Department of Endocrinology and Nutrition, Hospital Regional Universitario de Málaga, IBIMA Plataforma BIONAND, Instituto de Investigación Biomédica de Málaga, Faculty of Medicine, University of Málaga, 29010 Málaga, Sp…
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: José Ignacio Martínez-Montoro, José Juan Aparicio-Sánchez, Belén Pimentel, Maria Luisa Alamillo, Yesika Díaz, José Carlos Fernández-García
Förderung
- Instituto de Salud Carlos III
- AstraZeneca (Spain)
- Fondo Europeo de Desarrollo Regional
Zitieren
APA
Martínez-Montoro, J. I., Aparicio-Sánchez, J. J., Pimentel, B., Juárez-Campo, M., Alamillo, M. L., Díaz, Y., & Fernández-García, J. C. (2026). Five-Year Cardiorenal Outcomes and Longitudinal Chronic Kidney Disease Screening in People with Type 2 Diabetes Managed by Endocrinologists: A Nationwide Retrospective Cohort Study. Medical Sciences, 14(4), 506. https://doi.org/10.3390/medsci14040506
Vancouver
Martínez-Montoro JI, Aparicio-Sánchez JJ, Pimentel B, Juárez-Campo M, Alamillo ML, Díaz Y, et al. Five-Year Cardiorenal Outcomes and Longitudinal Chronic Kidney Disease Screening in People with Type 2 Diabetes Managed by Endocrinologists: A Nationwide Retrospective Cohort Study. Medical Sciences. 2026;14(4):506. doi:10.3390/medsci14040506
BibTeX
@article{MartnezMontoro2026,
author = {Martínez-Montoro, José Ignacio and Aparicio-Sánchez, José Juan and Pimentel, Belén and Juárez-Campo, Mónica and Alamillo, Maria Luisa and Díaz, Yesika and Fernández-García, José Carlos},
title = {Five-Year Cardiorenal Outcomes and Longitudinal Chronic Kidney Disease Screening in People with Type 2 Diabetes Managed by Endocrinologists: A Nationwide Retrospective Cohort Study},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {4},
pages = {506},
doi = {10.3390/medsci14040506}
}
EUVIMED